Milestone Pharmaceuticals Inc. (MIST) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $1.10 (-4.35%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 16, 2025 | Mohit Bansal | Wells Fargo | $8.00 | +624.0% |
| Dec 15, 2025 | Brandon Folkes | H.C. Wainwright | $8.00 | +624.0% |
Top Analysts Covering MIST
MIST vs Sector & Market
| Metric | MIST | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +417.2% | +16365.6% | +18.0% |
| P/E Ratio | -2.46 | 3.01 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1M | $2M | $4M | 2 |
| 2026-12-31 | $2M | $5M | $8M | 3 |
| 2027-03-31 | $2M | $4M | $8M | 3 |
| 2027-06-30 | $3M | $6M | $9M | 2 |
| 2027-09-30 | $3M | $6M | $11M | 2 |
| 2027-12-31 | $4M | $8M | $14M | 3 |
| 2028-12-31 | $57M | $139M | $248M | 2 |
| 2029-12-31 | $94M | $230M | $411M | 3 |
| 2030-12-31 | $126M | $308M | $549M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.38 | $-0.20 | $-0.06 | 1 |
| 2026-12-31 | $-0.37 | $-0.20 | $-0.06 | 2 |
| 2027-03-31 | $-0.34 | $-0.18 | $-0.05 | 2 |
| 2027-06-30 | $-0.34 | $-0.18 | $-0.05 | 1 |
| 2027-09-30 | $-0.34 | $-0.18 | $-0.05 | 1 |
| 2027-12-31 | $-0.33 | $-0.18 | $-0.05 | 2 |
| 2028-12-31 | $-0.34 | $-0.17 | $-0.04 | 3 |
| 2029-12-31 | $0.06 | $0.27 | $0.54 | 2 |
| 2030-12-31 | $0.16 | $0.67 | $1.36 | 2 |
Frequently Asked Questions
What is the analyst consensus for MIST?
The consensus among 1 analysts covering Milestone Pharmaceuticals Inc. (MIST) is Buy with an average price target of $7.33.
What is the highest price target for MIST?
The highest price target for MIST is $8.00, set by Mohit Bansal at Wells Fargo on 2025-12-16.
What is the lowest price target for MIST?
The lowest price target for MIST is $8.00, set by Brandon Folkes at H.C. Wainwright on 2025-12-15.
How many analysts cover MIST?
1 analysts have issued ratings for Milestone Pharmaceuticals Inc. in the past 12 months.
Is MIST a buy or sell right now?
Based on 1 analyst ratings, MIST has a consensus rating of Buy (2.00/5) with a +417.2% upside to the consensus target of $7.33.
What are the earnings estimates for MIST?
Analysts estimate MIST will report EPS of $-0.20 for the period ending 2026-09-30, with revenue estimated at $2M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.